GST Reforms, RDI Scheme Give Indian Pharma a Boost in 2025; Innovation and Access to Drive Growth in 2026
New Delhi- The Indian pharmaceutical sector witnessed a decisive shift in 2025, driven by major GST reforms and the introduction of the Research Development Incentive (RDI) Scheme, with industry leaders describing the year as a turning point for long-term growth. … read more








